DocGo Inc.
DocGo Inc. (DCGO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dcgo · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DocGo Inc. (DCGO) measures how much investors pay for each dollar of the company's trailing earnings. DCGO's current PE ratio of N/A is calculated by dividing its stock price of $0.55 by its TTM earnings per share of -$1.90.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%26.7x
MedianQ3 · 75%84.4x
Max
At N/A, DCGO's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DocGo Inc.You DCGO | $54M | N/A | — | -$1.90 |
 Coya Therapeutics, Inc. COYA | $83M | N/A | — | -$1.27 |
 Immix Biopharma, Inc. IMMX | $428M | N/A | — | -$0.89 |
 Microbot Medical Inc. MBOT | $83M | N/A | — | -$0.29 |
 MacroGenics, Inc. MGNX | $247M | N/A | — | -$1.18 |
 InspireMD, Inc. NSPR | $38M | N/A | — | -$0.66 |
 Ovid Therapeutics Inc. OVID | $311M | N/A | — | -$0.24 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.84 | — | |
2024-12-31 FY2024 | 21.72x | $0.20 | -74.3% | |
2023-12-31 FY2023 | 84.37x | $0.07 | +307.7% | |
2022-12-31 FY2022 | 20.69x | $0.34 | -34.6% | |
2021-12-31 FY2021 | 31.62x | $0.30 | — | |
2020-12-31 FY2020 | — | $-0.14 | — | |
2019-12-31 FY2019 | — | $-0.20 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DocGo Inc. (DCGO) measures how much investors pay for each dollar of the company's trailing earnings. DCGO's current PE ratio of N/A is calculated by dividing its stock price of $0.55 by its TTM earnings per share of -$1.90.
Frequently asked questions
DCGO pe ratio · 6 questionsDCGO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.55 and TTM EPS of -$1.90. Data sourced from Financial Modeling Prep via DCGO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DocGo Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09